Final answer:
The statement indicating the need for further teaching is the client's belief that they should take montelukast when they first notice trouble breathing. Montelukast is not for rapid relief of asthma symptoms but for long-term management.
Step-by-step explanation:
The statement that should indicate the need for further teaching for a client taking montelukast (Singulair) is "I will take the medication when I first notice I am having trouble breathing." Montelukast is designed to prevent asthma attacks and control allergic rhinitis symptoms, not to treat acute asthma attacks. The patient should continue to use a fast-acting inhaler for immediate relief in the event of an asthma attack.
Montelukast should be taken regularly to prevent asthma and allergy symptoms, not on an as-needed basis. Therefore, the client may need further teaching about the correct use of this medication and how it fits into their overall asthma management plan.
It is indeed correct that the client can "take the medication with food or without," and they "may be able to decrease the use of a metered-dose inhaler" if the long-term control is well-maintained with montelukast. However, they would only need to have their liver function checked if there is a clinical indication as per the prescribing physician's discretion.